BRIMONIDINE CUTANEOUS GEL
Clinical Indication
Facial erythema of rosacea (fixed erythema not flushing)
Comments
Review after one month and discontinue if no benefit
Local guidance
Moved from simple amber status in Sept 2016
Date of classification
September 2016
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.